Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

First data on human lyme borreliosis in Kosovo: prospective evaluation of the disease from a tick bite perspective (CROSBI ID 309056)

Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija

Ponosheci-Biçaku, Albina ; Ahmeti, Salih ; Trkulja, Vladimir ; Biçaku, Ardian ; Tešović, Goran First data on human lyme borreliosis in Kosovo: prospective evaluation of the disease from a tick bite perspective // Vector borne and zoonotic diseases (Larchmont, N.Y.), 21 (2021), 4; 247-255. doi: 10.1089/vbz.2020.2717

Podaci o odgovornosti

Ponosheci-Biçaku, Albina ; Ahmeti, Salih ; Trkulja, Vladimir ; Biçaku, Ardian ; Tešović, Goran

engleski

First data on human lyme borreliosis in Kosovo: prospective evaluation of the disease from a tick bite perspective

Purpose: Lyme borreliosis (LB) occurs throughout Europe. No clinical and seroprevalence studies for LB in Kosovo have been publicly available thus far. Therefore, this study aimed to investigate LB from a tick bite perspective in the Pristina region, Kosovo. Methods: This single-center prospective observational study enrolled consecutive adult participants (≥18 years of age) with tick bite (embedded tick in the skin), who were examined at the Clinic of Infectious Diseases, Pristina, between January 2015 and August 2018. At the first visit related to the index tick bite, ticks (the complete ticks or parts of the ticks) were removed from the skin, blood samples were taken for serological tests, and antibiotic treatment was started when deemed necessary. The complete, undamaged ticks removed were proceeded for entomological identification. Participants were followed up at 2 months (serological tests were repeated) and 6 months after the index event for the development of clinical manifestations of LB and/or seroconversion against Borrelia burgdorferi. Results: A total of 380 subjects were included in the study. Most cases were seen in May and June in all study years. All 117 preserved ticks were identified as Ixodes ricinus. Immunoglobulin G seroprevalence among subjects during the first visit in the study was 28/380 (7.4%). Erythema migrans (EM) was clinically diagnosed in 74/380 patients (19.5%, 95% confidence interval 15.6- 23.8). Only 15 clinically diagnosed EM (in seronegative patients) were serologically confirmed with seroconversion (2 months later), 3.9% of all subjects included in the study. There were three cases with clinical manifestation between the second and third visit: EM recidivans, multiple erythema, or several nonspecific systemic symptoms. Doxycycline and amoxicillin were mainly used for the treatment of borrelial skin lesions. Conclusion: This assessment can help indicate the need for disease awareness and reinforce the importance of primary prevention measures, early diagnosis, and appropriate treatment.

borrelia burgdorferi ; erythema migrans ; ixodes ; tick(s).

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

21 (4)

2021.

247-255

objavljeno

1530-3667

1557-7759

10.1089/vbz.2020.2717

Povezanost rada

Kliničke medicinske znanosti

Poveznice
Indeksiranost